Source: Annual Congress 2003 - Clinical aspects and consequences of sleep related breathing disorders
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Peker, L. Grote, G. Johannsson, J. Hedner (Gothenburg, Sweden). The state and responsiveness of the renin-angiotensin-aldosterone system in obstructive sleep apnoea. Eur Respir J 2003; 22: Suppl. 45, 652

Member's Comments

No comment yet.

Related content which might interest you: Impact of CPAP treatment on sympathetic activity and renin-angiotensin-aldosterone system in normotensive men with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 294s Year: 2006 Comparisson of corrective effects of APAP and CPAP on disordered autonomic nervous system function in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007 Autonomic changes during obstructive and central apneas in patients with sleep apnea syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 333s Year: 2001 Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 ACE-inhibitors and obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 358s Year: 2005 Treatment of obstructive and central sleep apnoea in heart failure: practical options Source: Eur Respir Rev 2007; 16: 183-188 Year: 2007 The vascular micromilieu in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 780-782 Year: 2005 Catecholamine secretion in obstructive sleep apnoea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005 Coexistence of central sleep apnea or periodic breathing pattern in patients with congestive heart failure and obstructive sleep apnea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients Source: Eur Respir J 2004; 23: 255-262 Year: 2004 The relation between obstructive apneas in OSA patients and autonomic activity Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 The impact of obstructive sleep apnea syndrome on cardiovascular system in children Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Can leptin be used to treat obstructive sleep apnoea? Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 The velumount device for obstructive sleep apnoea Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Influence of treatment on leptin levels in patients with obstructive sleep apnoea Source: Eur Respir J 2004; 23: 601-604 Year: 2004 The metabolic consequences of obstructive sleep apnoea in children Source: Breathe 2009; 6: 111-114 Year: 2009 Amelioration of immune system activation in obstructive sleep apnea syndrome patients after continuous positive airway pressure treatment Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008 Cardiovascular and metabolic consequences of obstructive sleep apnoea Source: Eur Respir J 2001; 18: Suppl. 33, 519s Year: 2001 Hypertension and obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006